Literature DB >> 352138

Depressed delayed cutaneous hypersensitivity in alcoholic hepatitis.

N Snyder, J Bessoff, J M Dwyer, H O Conn.   

Abstract

Delayed cutaneous hypersensitivity was studied in 10 patients with severe alcoholic hepatitis, 9 patients with either inactive alcoholic cirrhosis or alcoholic fatty liver, and 10 agematched controls. The mean response of the alcoholic hepatitis group was significantly less compared to controls for SK-SD (P less than 0.001), mumps (P less than 0.001), trichophyton (P less than 0.025), and Candida albicans (P less than 0.025). Upon clinical recovery, the response of the 6 surviving patients with alcoholic hepatitis was similar to controls for 4 of the 5 antigens tested, and the improvements in response to SK-SD and Candida albicans were significant (P less than 0.02 and P less than 0.05). The mean percentage and absolute numbers of thymus-derived lymphocytes were significantly less in the alcoholic hepatitis group compared with controls. Both the alcoholic hepatitis patients and patients with less advanced alcoholic liver disease had a diminished response to concanavalin A and phytohemagglutinin. This study demonstrates a reversible depression of delayed cutaneous hypersensitivity in alcoholic hepatitis. Several mechanisms may help account for this finding. We recommend that skin tests in patients with alcoholic hepatitis be interpreted with this phenomenon in mind.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 352138     DOI: 10.1007/bf01072420

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


  16 in total

Review 1.  Immunologic reactivity and alcoholic liver disease.

Authors:  R K Zetterman; C M Leevy
Journal:  Bull N Y Acad Med       Date:  1975-04

2.  T rosettes in alcoholic cirrhosis of the liver.

Authors:  M R Berenyi; B Straus; L Avila
Journal:  JAMA       Date:  1975-04-07       Impact factor: 56.272

3.  Editorial: Measurement of delayed skin-test responses.

Authors:  J E Sokal
Journal:  N Engl J Med       Date:  1975-09-04       Impact factor: 91.245

4.  Adrenocorticosteroid therapy in alcoholic hepatitis. A prospective, double-blind randomized study.

Authors:  B L Blitzer; M G Mutchnick; P H Joshi; M M Phillips; J M Fessel; H O Conn
Journal:  Am J Dig Dis       Date:  1977-06

5.  Reduction in circulating T lymphocytes in alcoholic liver disease.

Authors:  I M Bernstein; K H Webster; R C Williams; R G Strickland
Journal:  Lancet       Date:  1974-08-31       Impact factor: 79.321

6.  Delayed hypersensitivity in alcoholic cirrhosis.

Authors:  B Straus; M R Berenyi; J M Huang; E Straus
Journal:  Am J Dig Dis       Date:  1971-06

7.  Defective chemotaxis associated with a serum inhibitor in cirrhotic patients.

Authors:  A N DeMeo; B R Andersen
Journal:  N Engl J Med       Date:  1972-04-06       Impact factor: 91.245

8.  Inhibition of PHA-stimulated lymphocyte transformation by plasma from patients with advanced alcoholic cirrhosis.

Authors:  C C Hsu; C M Leevy
Journal:  Clin Exp Immunol       Date:  1971-05       Impact factor: 4.330

9.  Lymphocyte cytotoxicity for isolated hepatocytes in alcoholic liver disease.

Authors:  A M Cochrane; A Moussouros; B Portmann; I G McFarlane; A D Thomson; R Williams
Journal:  Gastroenterology       Date:  1977-05       Impact factor: 22.682

10.  Localization of T and B cells and alpha fetoprotein in hepatic biopsies from patients with liver disease.

Authors:  G Husby; R G Strickland; J L Caldwell; R C Williams
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

View more
  5 in total

1.  Mechanisms by which chronic ethanol feeding limits the ability of dendritic cells to stimulate T-cell proliferation.

Authors:  Ji Fan; Michelle R Edsen-Moore; Lucas E Turner; Robert T Cook; Kevin L Legge; Thomas J Waldschmidt; Annette J Schlueter
Journal:  Alcohol Clin Exp Res       Date:  2010-10-06       Impact factor: 3.455

Review 2.  Corticosteroids in liver disease: possible mechanisms of action, pharmacology, and rational use.

Authors:  A R Tanner; L W Powell
Journal:  Gut       Date:  1979-12       Impact factor: 23.059

3.  Interleukin 2 activity in chronic liver disease and the effect of in vitro alpha-interferon.

Authors:  S Saxena; K T Nouri-Aria; M G Anderson; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

Review 4.  AIDS, drugs of abuse and the immune system: a complex immunotoxicological network.

Authors:  R Pillai; B S Nair; R R Watson
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

5.  Alcohol abuse and stage of HIV disease in intravenous drug abusers.

Authors:  G Lake-Bakaar; R Grimson
Journal:  J R Soc Med       Date:  1996-07       Impact factor: 18.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.